1. Production of Trimeric SARS-CoV-2 Spike Protein by CHO Cells for Serological COVID-19 Testing
- Author
-
Tuck Seng Wong, Mark J. Dickman, Stephen R.P. Jaffé, Joseph M. Scarrott, David C. James, Yusuf B. Johari, Kang Lan Tee, Théo Mozzanino, Adam J. Brown, Thilo H. Pohle, Abayomi Oluwanbe Johnson, Philip J. Jackson, Ravishankar Sargur, Sheetal Maisuria, and Amina Bhayat-Cammack
- Subjects
chemistry.chemical_classification ,biology ,Chinese hamster ovary cell ,HEK 293 cells ,Trimer ,Molecular biology ,law.invention ,Antigen ,Affinity chromatography ,chemistry ,law ,biology.protein ,Recombinant DNA ,Antibody ,Glycoprotein - Abstract
We describe scalable and cost-efficient production of full length, His-tagged SARS-CoV-2 spike glycoprotein trimer by CHO cells that can be used to detect SARS-CoV-2 antibodies in patient sera at high specificity and sensitivity. Transient production of spike in both HEK and CHO cells mediated by PEI was increased significantly (up to 10.9-fold) by a reduction in culture temperature to 32°C to permit extended duration cultures. Based on these data GS-CHO pools stably producing spike trimer under the control of a strong synthetic promoter were cultured in hypothermic conditions with combinations of bioactive small molecules to increase yield of purified spike product 4.9-fold to 53 mg/L. Purification of recombinant spike by Nichelate affinity chromatography initially yielded a variety of co-eluting protein impurities identified as host cell derived by mass spectrometry, which were separated from spike trimer using a modified imidazole gradient elution. Purified CHO spike trimer antigen was used in ELISA format to detect IgG antibodies against SARS-CoV-2 in sera from patient cohorts previously tested for viral infection by PCR, including those who had displayed COVID-19 symptoms. The antibody assay, validated to ISO 15189 Medical Laboratories standards, exhibited a specificity of 100% and sensitivity of 92.3%. Our data show that CHO cells are a suitable host for the production of larger quantities of recombinant SARS-CoV-2 trimer which can be used as antigen for mass serological testing.
- Published
- 2020
- Full Text
- View/download PDF